Abstract: The present invention relates to a process for producing methyl methacrylate, comprising the following steps: A) producing methacrolein and B) reacting the methacrolein obtained in step A) in an oxidative esterification reaction to give methyl methacrylate, characterized in that the two steps A) and B) take place in a liquid phase at a pressure of from 2 to 100 bar, and step B) is carried out in the presence of a heterogeneous noble-metal-containing catalyst comprising metals and/or comprising metal oxides.
Type:
Grant
Filed:
October 16, 2018
Date of Patent:
September 8, 2020
Assignee:
RÖHM GMBH
Inventors:
Steffen Krill, Torsten Balduf, Martin Koestner, Matthias Groemping, Alexander Lygin, Rudolf Burghardt
Abstract: A bio-renewable flame-retardant compound is disclosed. The bio-renewable flame-retardant compound includes a cyclic structure formed in a reaction with a bio-renewable diene.
Type:
Grant
Filed:
September 19, 2018
Date of Patent:
August 25, 2020
Assignee:
International Business Machines Corporation
Inventors:
Brandon M. Kobilka, Jacob T. Porter, Jason T. Wertz, Joseph Kuczynski
Abstract: A method for the manufacture of perfluorinated compounds is herein disclosed. In particular, the method is useful for the manufacture of perfluorooxyalkyl carboxylic acid salts which can be used as surfactants. The method envisages the fluorination or a fluoroformate of an alcohol comprising a —CH2OCH2-moiety at a temperature equal to or higher than 20° C. and allows obtaining high yields and selectivity.
Type:
Grant
Filed:
March 28, 2017
Date of Patent:
August 11, 2020
Assignee:
SOLVAY SPECIALTY POLYMERS ITALY S.P.A.
Inventors:
Marco Galimberti, Vito Tortelli, Emanuela Antenucci, Giuseppe Marchionni
Abstract: The present disclosure provides a PdIn alloy catalyst including a carrier and Pd metal particles supported by the carrier, the carrier is a nitrogen-doped porous carbon composite material having a plurality of passages, Pd metal particles are distributed in the plurality of passages, the nitrogen-doped porous carbon composite material includes a nitrogen-doped porous carbon material, a plurality of indium oxide particles, and In metal particles. The In metal particles are exposed through the plurality of passages, the plurality of indium oxide particles are uniformly distributed in the nitrogen-doped porous carbon material, and In atoms of the In metal particles migrated to surfaces of Pd particles selectively occupy edge and corner positions of metal lattice of Pd metal particles. The present disclosure further provides a method for manufacturing the PdIn alloy catalyst and application thereof.
Abstract: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
Type:
Grant
Filed:
June 28, 2018
Date of Patent:
August 4, 2020
Assignee:
NOVARTIS AG
Inventors:
Jeremy Lee Baryza, Rohan Eric John Beckwith, Keith Bowman, Crystal Byers, Tanzina Fazal, Gabriel Grant Gamber, Cameron Chuck-munn Lee, Ritesh Bhanudasji Tichkule, Chandra Vargeese, Shuangxi Wang, Laura Ellen West, Thomas Zabawa, Junping Zhao
Abstract: The present invention relates to hexagonal hollow rods and a porous single crystalline structure, namely Form II of trimesic acid of Formula (A) and a process for preparation thereof. The present invention also discloses that the new solid porous single crystalline Form II of trimesic acid shows high adsorption for Rhodamine B (RHB) dye.
Type:
Grant
Filed:
May 2, 2019
Date of Patent:
August 4, 2020
Assignee:
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
Abstract: The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1?-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1?-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.
Type:
Grant
Filed:
August 21, 2019
Date of Patent:
July 14, 2020
Assignee:
Roivant Sciences GmbH
Inventors:
Stéphane De Lombaert, Daniel R. Goldberg
Abstract: Organic colorant represented by General Formula (1) below: where in the General Formula (1), R1 and R2 each independently represent C1-C20 alkyl group, C1-C20 alkenyl group, phenyl group, naphthyl group, or group represented by —(CH2)n—COO—R3, —(CH2)n—R4, —(CH2)n—CONH—R5, —CR6R7—COO—R8, or —(CH2)n—OCOCH3; R3 represents hydrogen atom or C1-C2 alkyl group; R4 represents hydroxy group, C1-C2 alkoxy group, C2-C5 alkenyloxy group, SO3Na group, OSO3Na group, phenyl group, phenylalkyl group, naphthyl group, or naphthylalkyl group; R5 represents C1-C20 alkyl group, C1-C20 alkenyl group, or C1-C12 hydroxyalkyl group; R6 represents hydrogen atom or methyl group; R7 represents C1-C4 alkyl group; R8 represents C1-C5 alkyl group; and n is integer of from 1 to 12.
Type:
Grant
Filed:
July 5, 2018
Date of Patent:
July 7, 2020
Assignees:
Ricoh Company, Ltd., Tokyo University of Science Foundation
Abstract: The present invention relates to a lubricant base oil containing an aromatic ester lubricant represented by Chemical Formula 1 and to a method for preparing the aromatic ester lubricant. By containing an aromatic ester lubricant, the lubricant base oil exhibits an excellent dispersibility and fluidity and is ecofriendly due to a high biodegradability. In addition, the method for preparing the aromatic ester lubricant does not generate such toxic substances as S, N, aromatic compounds and heavy metals and enables an easy control of the physical properties of a desired lubricant base oil by selecting a suitable alcohol compound to be introduced for an esterification reaction.
Type:
Grant
Filed:
July 30, 2018
Date of Patent:
June 30, 2020
Assignees:
SK Innovation Co., Ltd., SK Lubricants Co., Ltd.
Abstract: The present invention relates to a novel chiral phase-transfer catalyst, and a method for preparing an alpha-amino acid by using the same. According to the present invention, an alpha-amino acid of high optical purity could be synthesized in a high yield under an easy industrially applicable reaction condition by using a novel cinchona alkaloid compound as a chiral phase-transfer catalyst, and thus the present invention can be used as a key technique of the asymmetric alpha-amino acid synthesis and preparation field.
Type:
Grant
Filed:
February 6, 2017
Date of Patent:
June 30, 2020
Inventors:
Kee Pyung Nahm, Yeon Ji Lee, Bae Geun Lim, Seung A Woo, Ji Inn Oh, Won Gyoung Son
Abstract: The invention provides a pH-sensitive linker that can simultaneously bind metallic nanoparticles and one or more agents with various molecular size. The linker of the invention can deliver the agents into cells involved in disease processes or close to cells so that the agents can selectively target and effect on the cells. The target delivery provided by the linker of the invention can be used for example for disease sensing, imaging, drug delivery, and therapy.
Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same, for treating a neurodegenerative diseases.
Type:
Grant
Filed:
September 24, 2015
Date of Patent:
June 9, 2020
Assignee:
MEGABIOWOOD CO., LTD
Inventors:
Ki Duk Park, ChangJoon Justin Lee, Dong Jin Kim, Ae Nim Pae, Hyun Ah Choo, Sun Joon Min, Yong Koo Kang, Yun Kyung Kim, Hyo Jung Song, Ji Won Choi, Min Ho Nam, Jun Young Heo, Seul Ki Yeon, Bo Ko Jang, Eun Ji Ju, Seon Mi Jo, Jong-Hyun Park
Abstract: Disclosed are novel branched amphiphilic lipids, in particular novel branched amphiphilic lipids of general formula (II). Also disclosed is a method of synthesis for the compounds of formula (II), from unsaturated amphiphilic compounds of general formula (I). Further disclosed is the use of the compounds of general formula (II) and of the lipoplexes obtained by formulation of the compounds of general formula (II) for applications, particularly transfection, in which improved fusion properties are desired.
Type:
Grant
Filed:
September 23, 2016
Date of Patent:
June 9, 2020
Assignees:
UNIVERSITÉ DE BRETAGNE OCCIDENTALE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), CENTRE HOSPITALIER RÉGIONAL ET UNIVERSITAIRE DE BREST
Inventors:
Paul-Alain Jaffrès, Hélène Couthon-Courvès, Damien Afonso, Tristan Montier, Tony Le Gall
Abstract: Process for hydrogenating toluenediamine (TDA) tar containing TDA and high boilers relative to TDA, including the step of contacting the toluenediamine tar with a heterogeneous hydrogenation catalyst comprising at least one metal selected from the group consisting of Ni, Co, Ru, Pd, Pt on at least one catalyst support selected from the group consisting of carbon, TiO2 and ZrO2, and with hydrogen under hydrogenating conditions.
Type:
Grant
Filed:
October 9, 2017
Date of Patent:
May 26, 2020
Assignee:
BASF SE
Inventors:
Armin Lange De Oliveira, Ines Lottenburger, Christian Bechtold, Thomas Heidemann
Abstract: Phenylhydrazine/anhydride adducts and anaerobic curable compositions using these adducts are provided. The compositions are particularly useful as adhesives and sealants.
Abstract: A method for synthesizing a ketoxime is provided. In a system of an aqueous carbonate solution, a reaction is performed on a ketone, ammonia and hydrogen peroxide by using a titanium-silicon molecular sieve as a catalyst to obtain the ketoxime. Moreover, a reaction progress is judged and an optimal reaction ratio is determined by a real-time monitoring of a pH value in a reaction system during the reaction. In the present invention, by monitoring the pH value in the reaction system, the progress of the reaction is judged, thereby determining the optimal reaction ratio. The pH of the system is further adjusted by an aqueous carbonate solution to increase the reaction velocity and conversion rate of the ammonia.
Type:
Grant
Filed:
November 1, 2017
Date of Patent:
May 19, 2020
Assignee:
CHEMICAL TECHNOLOGY ACADEMY OF SHANDONG PROVINCE
Abstract: The present invention provides a crystal of a monovalent cation salt of 3-hydroxyisovaleric acid (hereinafter, referred to as HMB), which is excellent in solubility and easy to handle, and a process for producing the crystal. A crystal of a monovalent cation salt of HMB is precipitated in an aqueous HMB solution containing a monovalent cation-containing compound and having a pH of 4.0 to 9.0, and the crystal of a monovalent cation salt of HMB is thereafter collected from the aqueous solution.
Type:
Grant
Filed:
November 18, 2016
Date of Patent:
May 12, 2020
Assignees:
KYOWA HAKKO BIO CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.
Abstract: This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).
Type:
Grant
Filed:
March 29, 2018
Date of Patent:
May 5, 2020
Assignee:
DOW AGROSCIENCES LLC
Inventors:
Paul R. LePlae, Jr., Thomas Barton, Xin Gao, James E. Hunter, William C. Lo, Joshodeep Boruwa, Raghuram Tangirala, Gerald B. Watson, John Herbert, David A. Demeter, Hemant Joshi